Phase II Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil Chemotherapy in Squamous Cell Carcinoma of the Oral Cavity With Molecular ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2006-2009

ABSTRACT

This is a Phase II study designed to test the efficacy of chemotherapy with docetaxel, cisplatinum (cisplatin) and 5-fluorouracil in patients with squamous cell carcinoma of the oral cavity to determine what effects these agents may have on cancer cells. Detailed Description This is a Phase II study designed to test the efficacy of chemotherapy with docetaxel, cisplatinum, and 5-fluorouracil in patients with squamous cell carcinoma of the oral cavity to determine what effects these agents may have on cancer cells. Approximately 60 patients will take part at multi-sites with potentially 20 patients participating at the Emory Winship Cancer Institute in Atlanta, Georgia. More... »

URL

https://clinicaltrials.gov/show/NCT00400205

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "This is a Phase II study designed to test the efficacy of chemotherapy with docetaxel, cisplatinum (cisplatin) and 5-fluorouracil in patients with squamous cell carcinoma of the oral cavity to determine what effects these agents may have on cancer cells.\n\nDetailed Description\nThis is a Phase II study designed to test the efficacy of chemotherapy with docetaxel, cisplatinum, and 5-fluorouracil in patients with squamous cell carcinoma of the oral cavity to determine what effects these agents may have on cancer cells. Approximately 60 patients will take part at multi-sites with potentially 20 patients participating at the Emory Winship Cancer Institute in Atlanta, Georgia.", 
    "endDate": "2009-09-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT00400205", 
    "keywords": [
      "Phase II", 
      "induction", 
      "cisplatin", 
      "Drug Therapy", 
      "squamous cell carcinoma", 
      "mouth", 
      "endpoint", 
      "Phase II study", 
      "efficacy", 
      "docetaxel", 
      "cisplatinum", 
      "Fluorouracil", 
      "patient", 
      "agent", 
      "cancer cell", 
      "multi-site", 
      "Winship Cancer Institute", 
      "Georgia"
    ], 
    "name": "Phase II Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil Chemotherapy in Squamous Cell Carcinoma of the Oral Cavity With Molecular Endpoints", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT00400205"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00003.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.417555.7", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.189967.8", 
        "type": "Organization"
      }
    ], 
    "startDate": "2006-08-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1007/s12105-013-0476-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001209237", 
          "https://doi.org/10.1007/s12105-013-0476-6"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT00400205"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT00400205'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT00400205'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT00400205'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT00400205'


 

This table displays all metadata directly associated to this object as RDF triples.

43 TRIPLES      16 PREDICATES      35 URIs      27 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT00400205 schema:about anzsrc-for:3142
2 schema:description This is a Phase II study designed to test the efficacy of chemotherapy with docetaxel, cisplatinum (cisplatin) and 5-fluorouracil in patients with squamous cell carcinoma of the oral cavity to determine what effects these agents may have on cancer cells. Detailed Description This is a Phase II study designed to test the efficacy of chemotherapy with docetaxel, cisplatinum, and 5-fluorouracil in patients with squamous cell carcinoma of the oral cavity to determine what effects these agents may have on cancer cells. Approximately 60 patients will take part at multi-sites with potentially 20 patients participating at the Emory Winship Cancer Institute in Atlanta, Georgia.
3 schema:endDate 2009-09-01T00:00:00Z
4 schema:keywords Drug Therapy
5 Fluorouracil
6 Georgia
7 Phase II
8 Phase II study
9 Winship Cancer Institute
10 agent
11 cancer cell
12 cisplatin
13 cisplatinum
14 docetaxel
15 efficacy
16 endpoint
17 induction
18 mouth
19 multi-site
20 patient
21 squamous cell carcinoma
22 schema:name Phase II Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil Chemotherapy in Squamous Cell Carcinoma of the Oral Cavity With Molecular Endpoints
23 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT00400205
24 schema:sdDatePublished 2019-03-07T15:22
25 schema:sdLicense https://scigraph.springernature.com/explorer/license/
26 schema:sdPublisher N5a474c5b9af94f53a0d7649209b53087
27 schema:sponsor https://www.grid.ac/institutes/grid.189967.8
28 https://www.grid.ac/institutes/grid.417555.7
29 schema:startDate 2006-08-01T00:00:00Z
30 schema:subjectOf sg:pub.10.1007/s12105-013-0476-6
31 schema:url https://clinicaltrials.gov/show/NCT00400205
32 sgo:license sg:explorer/license/
33 sgo:sdDataset clinical_trials
34 rdf:type schema:MedicalStudy
35 N5a474c5b9af94f53a0d7649209b53087 schema:name Springer Nature - SN SciGraph project
36 rdf:type schema:Organization
37 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
38 rdf:type schema:DefinedTerm
39 sg:pub.10.1007/s12105-013-0476-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001209237
40 https://doi.org/10.1007/s12105-013-0476-6
41 rdf:type schema:CreativeWork
42 https://www.grid.ac/institutes/grid.189967.8 schema:Organization
43 https://www.grid.ac/institutes/grid.417555.7 schema:Organization
 




Preview window. Press ESC to close (or click here)


...